Orbotech Ltd. today announced the worldwide introduction of its new PerFix™ Automated Optical Repair (AOR) system for shorts and excess copper - the first of its kind in the bare printed circuit board (PCB) production industry.

Delivering unmatched repair performance, PerFix AOR overcomes the limitations of manual repair to greatly reduce the scrapping of panels.

“We are very pleased to yet again pioneer a breakthrough production technology for the PCB industry”, commented Mr. Hanan Gino, President of the PCB Division at Orbotech Ltd. “By automatically fixing short defects which frequently cannot be repaired manually, this solution will enable manufacturers to achieve major operational cost savings, particularly as the complexity of board designs continues to increase. We have already installed several systems in manufacturing facilities worldwide and the results have been very favorable.”

Featuring Orbotech's breakthrough, patent-pending technology, PerFix employs the advanced image acquisition and image processing techniques of Orbotech’s field proven SIP Technology™ for AOI combined with superior laser control. PerFix achieves highly accurate, repeatable and reliable results for advanced PCB applications - any time, every time - which are not possible with manual repair.

Orbotech (NASDAQ/GSM SYMBOL: ORBK) is principally engaged in the design, development, manufacture, marketing and service of yield-enhancing and production solutions for specialized applications in the supply chain of the electronics industry. Orbotech’s products include automated optical inspection (“AOI”) and process control systems for bare and assembled printed circuit boards (“PCB”s) and for flat panel displays (“FPD”s), and imaging solutions for PCB production. Orbotech also markets computer-aided manufacturing and engineering (“CAM”) solutions for PCB production. In addition, through its subsidiary, Orbograph Ltd., Orbotech develops and markets automatic check reading solutions to banks and other financial institutions, and has developed a proprietary technology for web-based, location-independent data entry for check processing and forms processing; and, through its subsidiaries, Orbotech Medical Denmark A/S and Orbotech Medical Solutions Ltd., is engaged in the research and development, manufacture and sale of specialized products for application in medical nuclear imaging. Of Orbotech’s employees, more than one quarter are scientists and engineers, who integrate their multi-disciplinary knowledge, talents and skills to develop and provide sophisticated solutions and technologies designed to meet customers’ long-term needs. Orbotech maintains its headquarters and its primary research, development and manufacturing facilities in Israel, and more than 30 offices worldwide. Orbotech’s extensive network of marketing, sales and customer support teams throughout North America, Europe, the Pacific Rim, China and Japan deliver its knowledge and expertise directly to customers the world over. For more information visit www.orbotech.com.

Except for historical information, the matters discussed in this press release are forward-looking statements that are subject to certain risks and uncertainties which could cause the actual results to differ materially from those projected, including industry trends, the timing and strength of product and service offerings, changes in business or pricing strategies, changes in the prevailing political and regulatory framework in which the relevant parties operate or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis and other risks detailed from time to time in the Company’s SEC reports. The Company assumes no obligation to update the information in this press release.

COMPANY CONTACTS:
Adrian Auman	Michelle Harnish
Corporate Vice President of	Marketing Communications Manager
Finance and Investor Relations	Orbotech, Inc.
Orbotech Ltd.	+1-978-901-5120
+972-8-942-3560